The study estimates the global Bioabsorbable Stent/Scaffold Market size for 2017 and projects its demand till 2022. Bioabsorbable Stent/Scaffold Market to analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders. Bioabsorbable Stent/Scaffold Market to analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information of the report.
- Agency -.
In 2017, Europe is expected to account for the largest share of the global bioresorbable stents market. The dominance of European region is attributed to factors like increasing regulatory approvals for stents which will facilitate their commercialization and rising research activities for development of bioresorbable stents.
Also, North America is expected to register the highest CAGR during the forecast period. The high growth in this regional segment is attributed to the increasing prevalence of CAD and PAD, patient preference for minimally invasive therapies, unhealthy lifestyle habits, and huge patient pool are enabling this market to grow in this region.
- Agency -.
Complete report on “Bioabsorbable Stent/Bioresorbable Scaffold Market” spread across 138 pages, profiling 15+ companies and supported with 73 tables and 33 figures is now available at www.rnrmarketresearch.com/bioabsor…rket-report.html
The global bioresorbable stents market is expected to reach USD 417.2 million by 2022 from USD 223.6 million in 2016, at a CAGR of 11.5% during the forecast period. Growing aging population susceptible to coronary and peripheral artery diseases, rising PCI procedures, increasing focus of companies on clinical trials of bioresorbable stents, increasing adoption of these stents by physicians and patients, and patients’ preference for minimally invasive therapies are factors that are expected to drive the market growth in future.
Target Audience for this Report:
- Bioabsorbable stent manufacturing companies
- Pharmaceutical manufacturing companies
- Healthcare institutions (hospitals and clinics)
- Stent distributors and suppliers
- Research institutes
- Venture capitalists
- Health insurance payers
- Market research and consulting firms
Based on end users, the market is segmented into hospitals and cardiac centers. The hospitals segment is expected to dominate the market.
The dominance of this segment is attributed to the increasing need of surgeries, growing risk of CAD and PAD, and improved reimbursement scenario for hospitals.
Get “Bioabsorbable Stent/Bioresorbable Scaffold Market” Available at www.rnrmarketresearch.com/contacts…ount?rname=616208
Top 15 prominent players in the market include Abbott, REVA Medical, Inc., Elixir Medical Corporation, KYOTO MEDICAL PLANNING Co., Ltd., BIOTRONIK, Amaranth Medical, Inc., Arterial Remodeling Technologies, Meril Life Sciences Pvt. Ltd., Arterius Limited, LEPU MEDICAL TECHNOLOGY CO., LTD., Boston Scientific Corporation, HangZhou HuaAn Biotechnology Co.,Ltd, S3V Vascular Technologies, QualiMed, SMT, TEPHA INC, Manli Cardiology Ltd., ORBUSNEICH, 480 Biomedical, Zorion Medical Inc, Lifetech Scientific (Shenzhen) Co., Ltd
Fundamental Key Point from Table of Content
FDA and Ce Approvals
PMA Approvals and Government Certificates
Bioresorbable Stents Market, By Material
Bioresorbable Polymer-Based Stents
Bioresorbable Metallic Stents
Bioresorbable Stents Market, By Absorption Rate
Category: Market Research Publishers and RetailersCompany profile: RnRMarketResearch.com is an online database of market research reports offers in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.
For more information: